G01N 2333/5425
Il-9
G01N2333/5425 (Il-9) appears on 5 US grants and 16 published applications in this corpus.
Search patents in G01N- Granted patents
- 5
- Published applications
- 16
- Assignees
- 10
- Inventors
- 26
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 4 |
| 2024 | 1 | 0 |
| 2025 | 1 | 3 |
By publication year.
Recent patents
- Signature of TL1A (TNFSF15) signaling pathway8 Apr 2025US 12,269,873 B2Cedars-Sinai Medical Center
- Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases3 Dec 2024US 12,157,772 B2National Center of Neurology and Psychiatry
- Signature of TL1A (TNFSF15) signaling pathway26 Apr 2022US 11,312,768 B2Cedars-Sinai Medical Center
- Signature of TL1A (TNFSF15) signaling pathway11 Jun 2019US 10,316,083 B2Cedars-Sinai Medical Center
- Biomarkers for the identification of liver damage30 May 2017US 9,664,693 B2The Charlotte-Mecklenburg Hospital Authority
- Signature of tl1a (tnfsf15) signaling pathway11 Dec 2025US 2025/0376514 A1Cedars-Sinai Medical Center
- System and methods for diagnosing acute interstitial nephritis23 Oct 2025US 2025/0327815 A1
- Breast implant-associated anaplastic large cell lymphoma diagnostic test3 Apr 2025US 2025/0110131 A1Rhode Island Hospital
- Aptamers that target cxcl99 Nov 2023US 2023/0358760 A1Leibniz Universitat Hannover
- Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokinerelease syndrome and cytokine storm associated disorders26 Oct 2023US 2023/0338473 A1Bioniz, LLC
Most cited
By later US patents